造血干细胞移植后眼部移植物抗宿主病的发生率、危险因素与并发症
这项单中心回顾性观察性病例系列研究纳入2005至2020年间接受造血干细胞移植的283例患者,按国际慢性眼部GVHD共识组标准诊断眼部GVHD。眼部GVHD的5年累积发生率为49.7%,受者年龄、女性、外周血干细胞使用及既往急性GVHD是显著预测因素,移植后可出现白内障、角膜溃疡等视力威胁并发症。
要点
- 眼部GVHD 5年累积发生率达49.7%,近半数移植受者受累。
- 受者年龄、女性、外周血干细胞及既往急性GVHD为显著预测因素。
- 移植后需警惕白内障、角膜溃疡、角膜穿孔等视力威胁并发症。
核心结论
- 近半数患者在造血干细胞移植后5年内发生眼部GVHD。
- 年龄较大、女性、使用外周血干细胞及既往急性GVHD是眼部GVHD的显著预测因素。
- 血液科与眼科医生应认识其视力威胁性并发症。
研究设计与样本
- 回顾性观察性病例系列研究,纳入2005至2020年间接受造血干细胞移植的283例患者。
- 眼部GVHD按国际慢性眼部GVHD共识组标准诊断。
- 采用Cox比例风险模型评估眼部GVHD的潜在危险因素。
主要发现
- 眼部GVHD累积发生率1年为19.7%、2年29.3%、3年40.7%、4年47.2%、5年49.7%。
关键数值与推荐
- 眼部GVHD诊断依据国际慢性眼部GVHD共识组标准。
- 移植后眼部并发症包括白内障、角膜溃疡、角膜穿孔、泪道阻塞、疱疹性角膜炎和巨细胞病毒性视网膜炎。
临床怎么用
- 对接受造血干细胞移植的患者,尤其具备年龄较大、女性、使用外周血干细胞或既往急性GVHD者,应警惕眼部GVHD。
- 血液科与眼科需协作监测移植后视力威胁性并发症。
局限性
- 本研究为单中心回顾性观察性病例系列,可能存在选择偏倚与信息偏倚。
- 原文未报告多中心外部验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this research was to evaluate the incidence, risk factors, and complications of ocular graft-versus-host disease (GVHD) in a large single-center study. DESIGN: Retrospective observational case series. METHODS: This study included 283 patients who underwent hematopoietic stem cell transplantation (HSCT) between 2005 and 2020. Ocular GVHD was diagnosed according to International Chronic Ocular GVHD Consensus Group criteria. Potential risk factors for ocular GVHD were evaluated using the Cox proportional hazards model. RESULTS: The cumulative incidence of ocular GVHD was 19.7% at 1 year, 29.3% at 2 years, 40.7% at 3 years, 47.2% at 4 years, and 49.7% at 5 years. Ocular GVHD was significantly associated with recipient age (hazard ratio [HR]: 1.228; 95% confidence interval [CI]: 1.033-1.459; P = .020); female sex (HR: 1.797; 95% CI: 1.195-2.703; P = .005); peripheral blood stem cell use (PBSC) (HR: 2.079; 95% CI: 1.268-3.411; P = .004); and previous acute GVHD (HR: 1.276; 95% CI: 1.073-1.518; P = .006). Ocular complications after HSCT included cataract, corneal ulcer, corneal perforation, lacrimal obstruction, herpetic keratitis, and cytomegalovirus retinitis. CONCLUSIONS: Half of patients developed ocular GVHD in the 5 years following HSCT. Older age, female sex, use of PBSC, and acute GVHD disease were significant predictors of ocular GVHD. Hematologists and ophthalmologists should be aware of its vision threating complications.
引用
- Pellegrini M, Bernabei F, Barbato F, et al. Incidence, Risk Factors and Complications of Ocular Graft-Versus-Host Disease Following Hematopoietic Stem Cell Transplantation. Am J Ophthalmol. 2021. PMID: 33626365. doi:10.1016/j.ajo.2021.02.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。